nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisdexamfetamine—L-Lysine—SLC22A4—Crohn's disease	0.0475	0.542	CrCbGaD
Lisdexamfetamine—Amphetamine—SLC22A5—Crohn's disease	0.0208	0.238	CrCbGaD
Lisdexamfetamine—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.0196	0.0214	CcSEcCtD
Lisdexamfetamine—Methamphetamine—SLC22A5—Crohn's disease	0.0193	0.22	CrCbGaD
Lisdexamfetamine—Immune system disorder—Mercaptopurine—Crohn's disease	0.0168	0.0184	CcSEcCtD
Lisdexamfetamine—Malnutrition—Mercaptopurine—Crohn's disease	0.0162	0.0177	CcSEcCtD
Lisdexamfetamine—Libido decreased—Mesalazine—Crohn's disease	0.0157	0.0172	CcSEcCtD
Lisdexamfetamine—Mania—Prednisone—Crohn's disease	0.0146	0.016	CcSEcCtD
Lisdexamfetamine—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.0145	0.0158	CcSEcCtD
Lisdexamfetamine—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.0144	0.0158	CcSEcCtD
Lisdexamfetamine—Affect lability—Mesalazine—Crohn's disease	0.0143	0.0157	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.0137	0.015	CcSEcCtD
Lisdexamfetamine—Abdominal pain upper—Mesalazine—Crohn's disease	0.0133	0.0146	CcSEcCtD
Lisdexamfetamine—Skin disorder—Mercaptopurine—Crohn's disease	0.0128	0.014	CcSEcCtD
Lisdexamfetamine—Anorexia—Mercaptopurine—Crohn's disease	0.0126	0.0138	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.0122	0.0134	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Azathioprine—Crohn's disease	0.0117	0.0128	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Mercaptopurine—Crohn's disease	0.0115	0.0126	CcSEcCtD
Lisdexamfetamine—Weight increased—Mesalazine—Crohn's disease	0.0115	0.0126	CcSEcCtD
Lisdexamfetamine—Weight decreased—Mesalazine—Crohn's disease	0.0114	0.0125	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.0114	0.0125	CcSEcCtD
Lisdexamfetamine—Depression—Mesalazine—Crohn's disease	0.0112	0.0123	CcSEcCtD
Lisdexamfetamine—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.0111	0.0122	CcSEcCtD
Lisdexamfetamine—Hepatobiliary disease—Mesalazine—Crohn's disease	0.0106	0.0116	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Azathioprine—Crohn's disease	0.0105	0.0115	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Mercaptopurine—Crohn's disease	0.0104	0.0114	CcSEcCtD
Lisdexamfetamine—Hepatitis—Mesalazine—Crohn's disease	0.0101	0.011	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Azathioprine—Crohn's disease	0.00999	0.011	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Azathioprine—Crohn's disease	0.00997	0.0109	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00972	0.0107	CcSEcCtD
Lisdexamfetamine—Erythema multiforme—Mesalazine—Crohn's disease	0.00953	0.0104	CcSEcCtD
Lisdexamfetamine—Eye disorder—Mesalazine—Crohn's disease	0.00942	0.0103	CcSEcCtD
Lisdexamfetamine—Cardiac disorder—Mesalazine—Crohn's disease	0.00935	0.0103	CcSEcCtD
Lisdexamfetamine—Euphoric mood—Prednisone—Crohn's disease	0.00912	0.01	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Mesalazine—Crohn's disease	0.0091	0.00998	CcSEcCtD
Lisdexamfetamine—Mediastinal disorder—Mesalazine—Crohn's disease	0.00908	0.00995	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00903	0.00989	CcSEcCtD
Lisdexamfetamine—Mental disorder—Mesalazine—Crohn's disease	0.00883	0.00968	CcSEcCtD
Lisdexamfetamine—Nervousness—Mesalazine—Crohn's disease	0.00852	0.00934	CcSEcCtD
Lisdexamfetamine—Vomiting—Mercaptopurine—Crohn's disease	0.00839	0.00919	CcSEcCtD
Lisdexamfetamine—Rash—Mercaptopurine—Crohn's disease	0.00832	0.00912	CcSEcCtD
Lisdexamfetamine—Dermatitis—Mercaptopurine—Crohn's disease	0.00831	0.00911	CcSEcCtD
Lisdexamfetamine—Vision blurred—Mesalazine—Crohn's disease	0.00827	0.00906	CcSEcCtD
Lisdexamfetamine—Tremor—Mesalazine—Crohn's disease	0.00822	0.00901	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00814	0.00892	CcSEcCtD
Lisdexamfetamine—Angioedema—Mesalazine—Crohn's disease	0.00802	0.00879	CcSEcCtD
Lisdexamfetamine—Nausea—Mercaptopurine—Crohn's disease	0.00784	0.00859	CcSEcCtD
Lisdexamfetamine—Palpitations—Mesalazine—Crohn's disease	0.00775	0.0085	CcSEcCtD
Lisdexamfetamine—Skin disorder—Azathioprine—Crohn's disease	0.00763	0.00837	CcSEcCtD
Lisdexamfetamine—Affect lability—Prednisone—Crohn's disease	0.00759	0.00831	CcSEcCtD
Lisdexamfetamine—Hypertension—Mesalazine—Crohn's disease	0.00757	0.0083	CcSEcCtD
Lisdexamfetamine—Psychotic disorder—Prednisone—Crohn's disease	0.00753	0.00825	CcSEcCtD
Lisdexamfetamine—Anxiety—Mesalazine—Crohn's disease	0.00744	0.00816	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00742	0.00813	CcSEcCtD
Lisdexamfetamine—Irritability—Prednisone—Crohn's disease	0.00736	0.00806	CcSEcCtD
Lisdexamfetamine—Dry mouth—Mesalazine—Crohn's disease	0.0073	0.00801	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Mesalazine—Crohn's disease	0.00716	0.00785	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Mesalazine—Crohn's disease	0.00702	0.0077	CcSEcCtD
Lisdexamfetamine—Tachycardia—Mesalazine—Crohn's disease	0.00699	0.00766	CcSEcCtD
Lisdexamfetamine—Skin disorder—Mesalazine—Crohn's disease	0.00695	0.00762	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Mesalazine—Crohn's disease	0.00692	0.00759	CcSEcCtD
Lisdexamfetamine—Anorexia—Mesalazine—Crohn's disease	0.00682	0.00748	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.00679	0.00744	CcSEcCtD
Lisdexamfetamine—Insomnia—Mesalazine—Crohn's disease	0.00648	0.0071	CcSEcCtD
Lisdexamfetamine—Dyspnoea—Mesalazine—Crohn's disease	0.00638	0.007	CcSEcCtD
Lisdexamfetamine—Somnolence—Mesalazine—Crohn's disease	0.00636	0.00698	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Mesalazine—Crohn's disease	0.0063	0.00691	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Mesalazine—Crohn's disease	0.00622	0.00682	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Azathioprine—Crohn's disease	0.00621	0.00681	CcSEcCtD
Lisdexamfetamine—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00618	0.00677	CcSEcCtD
Lisdexamfetamine—Fatigue—Mesalazine—Crohn's disease	0.00617	0.00677	CcSEcCtD
Lisdexamfetamine—Erectile dysfunction—Prednisone—Crohn's disease	0.00613	0.00672	CcSEcCtD
Lisdexamfetamine—Constipation—Mesalazine—Crohn's disease	0.00612	0.00671	CcSEcCtD
Lisdexamfetamine—Weight increased—Prednisone—Crohn's disease	0.00606	0.00664	CcSEcCtD
Lisdexamfetamine—Weight decreased—Prednisone—Crohn's disease	0.00603	0.0066	CcSEcCtD
Lisdexamfetamine—Depression—Prednisone—Crohn's disease	0.00592	0.00649	CcSEcCtD
Lisdexamfetamine—Acute coronary syndrome—Prednisone—Crohn's disease	0.00585	0.00642	CcSEcCtD
Lisdexamfetamine—Myocardial infarction—Prednisone—Crohn's disease	0.00582	0.00638	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Azathioprine—Crohn's disease	0.00579	0.00635	CcSEcCtD
Lisdexamfetamine—Urticaria—Mesalazine—Crohn's disease	0.00569	0.00623	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Mesalazine—Crohn's disease	0.00566	0.0062	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Azathioprine—Crohn's disease	0.00538	0.00589	CcSEcCtD
Lisdexamfetamine—Hallucination—Prednisone—Crohn's disease	0.0053	0.00581	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Mesalazine—Crohn's disease	0.00527	0.00578	CcSEcCtD
Lisdexamfetamine—Dizziness—Azathioprine—Crohn's disease	0.0052	0.0057	CcSEcCtD
Lisdexamfetamine—Asthenia—Mesalazine—Crohn's disease	0.00514	0.00563	CcSEcCtD
Lisdexamfetamine—Vomiting—Azathioprine—Crohn's disease	0.005	0.00548	CcSEcCtD
Lisdexamfetamine—Eye disorder—Prednisone—Crohn's disease	0.00498	0.00546	CcSEcCtD
Lisdexamfetamine—Rash—Azathioprine—Crohn's disease	0.00496	0.00543	CcSEcCtD
Lisdexamfetamine—Dermatitis—Azathioprine—Crohn's disease	0.00495	0.00543	CcSEcCtD
Lisdexamfetamine—Headache—Azathioprine—Crohn's disease	0.00492	0.0054	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Mesalazine—Crohn's disease	0.0049	0.00537	CcSEcCtD
Lisdexamfetamine—Immune system disorder—Prednisone—Crohn's disease	0.00482	0.00528	CcSEcCtD
Lisdexamfetamine—Dizziness—Mesalazine—Crohn's disease	0.00473	0.00519	CcSEcCtD
Lisdexamfetamine—Mental disorder—Prednisone—Crohn's disease	0.00467	0.00512	CcSEcCtD
Lisdexamfetamine—Nausea—Azathioprine—Crohn's disease	0.00467	0.00512	CcSEcCtD
Lisdexamfetamine—Malnutrition—Prednisone—Crohn's disease	0.00464	0.00509	CcSEcCtD
Lisdexamfetamine—Vomiting—Mesalazine—Crohn's disease	0.00455	0.00499	CcSEcCtD
Lisdexamfetamine—Rash—Mesalazine—Crohn's disease	0.00451	0.00495	CcSEcCtD
Lisdexamfetamine—Dermatitis—Mesalazine—Crohn's disease	0.00451	0.00494	CcSEcCtD
Lisdexamfetamine—Headache—Mesalazine—Crohn's disease	0.00449	0.00492	CcSEcCtD
Lisdexamfetamine—Vision blurred—Prednisone—Crohn's disease	0.00437	0.00479	CcSEcCtD
Lisdexamfetamine—Agitation—Prednisone—Crohn's disease	0.00427	0.00467	CcSEcCtD
Lisdexamfetamine—Nausea—Mesalazine—Crohn's disease	0.00425	0.00466	CcSEcCtD
Lisdexamfetamine—Angioedema—Prednisone—Crohn's disease	0.00424	0.00465	CcSEcCtD
Lisdexamfetamine—Convulsion—Prednisone—Crohn's disease	0.00402	0.00441	CcSEcCtD
Lisdexamfetamine—Hypertension—Prednisone—Crohn's disease	0.00401	0.00439	CcSEcCtD
Lisdexamfetamine—Anxiety—Prednisone—Crohn's disease	0.00394	0.00432	CcSEcCtD
Lisdexamfetamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00392	0.0043	CcSEcCtD
Lisdexamfetamine—Anaphylactic shock—Prednisone—Crohn's disease	0.00379	0.00415	CcSEcCtD
Lisdexamfetamine—Nervous system disorder—Prednisone—Crohn's disease	0.00371	0.00407	CcSEcCtD
Lisdexamfetamine—Tachycardia—Prednisone—Crohn's disease	0.0037	0.00405	CcSEcCtD
Lisdexamfetamine—Skin disorder—Prednisone—Crohn's disease	0.00368	0.00403	CcSEcCtD
Lisdexamfetamine—Hyperhidrosis—Prednisone—Crohn's disease	0.00366	0.00401	CcSEcCtD
Lisdexamfetamine—Anorexia—Prednisone—Crohn's disease	0.00361	0.00396	CcSEcCtD
Lisdexamfetamine—Insomnia—Prednisone—Crohn's disease	0.00343	0.00375	CcSEcCtD
Lisdexamfetamine—Dyspepsia—Prednisone—Crohn's disease	0.00333	0.00365	CcSEcCtD
Lisdexamfetamine—Decreased appetite—Prednisone—Crohn's disease	0.00329	0.00361	CcSEcCtD
Lisdexamfetamine—Fatigue—Prednisone—Crohn's disease	0.00327	0.00358	CcSEcCtD
Lisdexamfetamine—Constipation—Prednisone—Crohn's disease	0.00324	0.00355	CcSEcCtD
Lisdexamfetamine—Urticaria—Prednisone—Crohn's disease	0.00301	0.0033	CcSEcCtD
Lisdexamfetamine—Body temperature increased—Prednisone—Crohn's disease	0.00299	0.00328	CcSEcCtD
Lisdexamfetamine—Hypersensitivity—Prednisone—Crohn's disease	0.00279	0.00306	CcSEcCtD
Lisdexamfetamine—Asthenia—Prednisone—Crohn's disease	0.00272	0.00298	CcSEcCtD
Lisdexamfetamine—Diarrhoea—Prednisone—Crohn's disease	0.00259	0.00284	CcSEcCtD
Lisdexamfetamine—Dizziness—Prednisone—Crohn's disease	0.0025	0.00275	CcSEcCtD
Lisdexamfetamine—Vomiting—Prednisone—Crohn's disease	0.00241	0.00264	CcSEcCtD
Lisdexamfetamine—Rash—Prednisone—Crohn's disease	0.00239	0.00262	CcSEcCtD
Lisdexamfetamine—Dermatitis—Prednisone—Crohn's disease	0.00239	0.00262	CcSEcCtD
Lisdexamfetamine—Headache—Prednisone—Crohn's disease	0.00237	0.0026	CcSEcCtD
Lisdexamfetamine—Nausea—Prednisone—Crohn's disease	0.00225	0.00247	CcSEcCtD
